NEW YORK, Dec 22 - Deltagen said Friday that it has signed Pfizer as the second licensee to its DeltaBase gene function database.

Under the terms of the agreement, Pfizer will have non-exclusive access to in vivo mammalian gene function information on 750 genes in DeltaBase, as well as access to corresponding DeltaBase intellectual property rights.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.